SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-15-019892
Filing Date
2015-11-05
Accepted
2015-11-05 17:18:38
Documents
13
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q insy20150930_10q.htm 10-Q 1226126
2 EXHIBIT 10.1 ex10-1.htm EX-10.1 86681
3 EXHIBIT 10.2 ex10-2.htm EX-10.2 184987
4 EXHIBIT 31.1 ex31-1.htm EX-31.1 11283
5 EXHIBIT 31.2 ex31-2.htm EX-31.2 11243
6 EXHIBIT 32 ex32.htm EX-32 9555
13 ex10-3img001.jpg GRAPHIC 5763
  Complete submission text file 0001437749-15-019892.txt   5386178

Data Files

Seq Description Document Type Size
7 EXHIBIT 101.INS insy-20150930.xml EX-101.INS 1092689
8 EXHIBIT 101.SCH insy-20150930.xsd EX-101.SCH 40687
9 EXHIBIT 101.CAL insy-20150930_cal.xml EX-101.CAL 36838
10 EXHIBIT 101.DEF insy-20150930_def.xml EX-101.DEF 289169
11 EXHIBIT 101.LAB insy-20150930_lab.xml EX-101.LAB 255865
12 EXHIBIT 101.PRE insy-20150930_pre.xml EX-101.PRE 310365
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35902 | Film No.: 151201692
SIC: 2834 Pharmaceutical Preparations